NR4A3 was identified as a tumor suppressor for acute myeloid leukemia (AML): deletion of NR4A3 led to the rapid development of AML in mice, and NR4A3 gene deletion is common in patients with AML [36]. The gene discussed is NR4A3; the disease is neoplasm.